Eléments de l'association

	Yves Agid	49
	Antiparkinson Agents (adverse effects)	43
	Yves Agid *Sauf* Antiparkinson Agents (adverse effects)"	41
	Antiparkinson Agents (adverse effects) *Sauf* Yves Agid"	35
	Yves Agid Et Antiparkinson Agents (adverse effects)	8
	Yves Agid Ou Antiparkinson Agents (adverse effects)	84
	*Corpus*	679

List of bibliographic references

Number of relevant bibliographic references: 8.

Ident.	Authors (with country if any)	Title
000303	Ebba Lohmann [France] ; Marie-Laure Welter [France] ; Valérie Fraix [France] ; Paul Krack [France] ; Suzanne Lesage [France] ; Sophie Laine [France] ; Marie-Laure Tanguy [France] ; Jean-Luc Houeto [France] ; Valérie Mesnage [France] ; Pierre Pollak [France] ; Alexandra Durr [France] ; Yves Agid [France] ; Alexis Brice [France]	Are parkin patients particularly suited for deep‐brain stimulation?
000432	C. Warren Olanow [États-Unis] ; Yves Agid [France] ; Yoshi Mizuno [Japon] ; Alberto Albanese [Italie] ; U. Bonucelli [Italie] ; Philip Damier [France] ; Justo De Yebenes [Espagne] ; Oscar Gershanik [Argentine] ; Mark Guttman [Canada] ; F. Grandas [Espagne] ; Mark Hallett [États-Unis] ; Ole Hornykiewicz [Autriche] ; Peter Jenner [Royaume-Uni] ; R. Katzenschlager [Royaume-Uni] ; William J. Langston [États-Unis] ; Peter Lewitt [États-Unis] ; Eldad Melamed [Israël] ; M. A. Mena [Espagne] ; P. P. Michel [France] ; Catherine Mytilineou [États-Unis] ; Jose A. Obeso [Espagne] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; R. Raisman-Vozari [France] ; Ali H. Rajput [Canada] ; Olivier Rascol [France] ; Christina Sampaio [Portugal] ; Fabrizio Stocchi [Italie]	Levodopa in the treatment of Parkinson's disease: Current controversies
000449	Bechir Jarraya [France] ; Anne-Marie Bonnet [France] ; Charles Duyckaerts [France] ; Jean-Luc Houeto [France] ; Philippe Cornu [France] ; Jean-Jacques Hauw [France] ; Yves Agid [France]	Parkinson's disease, subthalamic stimulation, and selection of candidates: A pathological study
000510	Olivier Rascol [France] ; I. Arnulf [France] ; H. Peyro-Saint Paul [France] ; C. Brefel-Courbon [France] ; M. Vidailhet [France] ; C. Thalamas [France] ; A. M. Bonnet [France] ; S. Descombes [France] ; B. Bejjani [France] ; N. Fabre [France] ; J. L. Montastruc [France] ; Yves Agid [France]	Idazoxan, an alpha‐2 antagonist, and L‐DOPA‐induced dyskinesias in patients with Parkinson's disease
000534	Franck Durif [France] ; Marie Vidailhet [France] ; Bérangère Debilly [France] ; Yves Agid [France]	Worsening of levodopa‐induced dyskinesias by motor and mental tasks
000545	Yves Agid [France] ; E. Ahlskog [France] ; A. Albanese [France] ; D. Calne [France] ; T. Chase [France] ; J. De Yebenes [France] ; S. Factor [France] ; S. Fahn [France] ; O. Gershanik [France] ; C. Goetz [France] ; W. Koller [France] ; M. Kurth [France] ; A. Lang [France] ; A. Lees [France] ; P. Lewitt [France] ; D. Marsden [France] ; E. Melamed [France] ; P. P. Michel [France] ; Y. Mizuno [France] ; J. Obeso [France] ; W. Oertel [France] ; W. Olanow [France] ; Werner Poewe [France] ; Pierre Pollak [France] ; S. Przedzorski [France] ; N. Quinn [France] ; R. Raisman-Vozari [France] ; A. Rajput [France] ; F. Stocchi [France] ; E. Tolosa [France]	Levodopa in the treatment of Parkinson's disease: A consensus meeting viewpoint
000553	M. Vidailhet [France] ; A. M. Bonnet [France] ; R. Marconi [France] ; F. Durif [France] ; Yves Agid [France]	The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease
000571	Bejjani [France] ; Philippe Damier [France] ; Isabelle Arnulf [France] ; Sawas Papadopoulos [France] ; Anne-Marie Bonnet [France] ; Marie Vidailhet [France] ; Yves Agid [France] ; Bernard Pidoux [France] ; Philippe Cornu [France] ; Didier Dormont [France] ; Claude Marsault [France]	Deep brain stimulation in Parkinson's disease: Opposite effects of stimulation in the pallidum

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024